Fanslow W - Search Results

1

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.

Cosman D, Müllberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, Kubin M, Chalupny NJ. Cosman D, et al. Among authors: fanslow w. Immunity. 2001 Feb;14(2):123-33. doi: 10.1016/s1074-7613(01)00095-4. Immunity. 2001. PMID: 11239445 Free article.

2

ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells.

Kubin M, Cassiano L, Chalupny J, Chin W, Cosman D, Fanslow W, Müllberg J, Rousseau AM, Ulrich D, Armitage R. Kubin M, et al. Among authors: fanslow w. Eur J Immunol. 2001 May;31(5):1428-37. doi: 10.1002/1521-4141(200105)31:5<1428::AID-IMMU1428>3.0.CO;2-4. Eur J Immunol. 2001. PMID: 11465099 Free article.

3

The interleukin-4 receptor: structure, function, and signal transduction.

Beckmann MP, Cosman D, Fanslow W, Maliszewski CR, Lyman SD. Beckmann MP, et al. Among authors: fanslow w. Chem Immunol. 1992;51:107-34. Chem Immunol. 1992. PMID: 1567539 Review. No abstract available.

4

Soluble forms of CD40 inhibit biologic responses of human B cells.

Fanslow WC, Anderson DM, Grabstein KH, Clark EA, Cosman D, Armitage RJ. Fanslow WC, et al. J Immunol. 1992 Jul 15;149(2):655-60. J Immunol. 1992. PMID: 1378075

5

Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family of natural killer cell activation antigens.

Ziegler SF, Ramsdell F, Hjerrild KA, Armitage RJ, Grabstein KH, Hennen KB, Farrah T, Fanslow WC, Shevach EM, Alderson MR. Ziegler SF, et al. Among authors: fanslow wc. Eur J Immunol. 1993 Jul;23(7):1643-8. doi: 10.1002/eji.1830230737. Eur J Immunol. 1993. PMID: 8100776

6

Identification of a novel low-affinity receptor for human interleukin-7.

Armitage RJ, Ziegler SF, Friend DJ, Park LS, Fanslow WC. Armitage RJ, et al. Among authors: fanslow wc. Blood. 1992 Apr 1;79(7):1738-45. Blood. 1992. PMID: 1558969 Free article.

7

The biology of the human ligand for CD40.

Spriggs MK, Fanslow WC, Armitage RJ, Belmont J. Spriggs MK, et al. Among authors: fanslow wc. J Clin Immunol. 1993 Nov;13(6):373-80. doi: 10.1007/BF00920012. J Clin Immunol. 1993. PMID: 7507124 Review. No abstract available.

8

Human IL-17: a novel cytokine derived from T cells.

Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RJ. Yao Z, et al. Among authors: fanslow wc. J Immunol. 1995 Dec 15;155(12):5483-6. J Immunol. 1995. PMID: 7499828

9

CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40.

Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK. Alderson MR, et al. Among authors: fanslow wc. J Exp Med. 1993 Aug 1;178(2):669-74. doi: 10.1084/jem.178.2.669. J Exp Med. 1993. PMID: 7688031 Free PMC article.

10

CD40 ligand is a T cell growth factor.

Armitage RJ, Tough TW, Macduff BM, Fanslow WC, Spriggs MK, Ramsdell F, Alderson MR. Armitage RJ, et al. Among authors: fanslow wc. Eur J Immunol. 1993 Sep;23(9):2326-31. doi: 10.1002/eji.1830230941. Eur J Immunol. 1993. PMID: 7690330

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page